An estimated 50 to 90 percent of digital device users in the U.S. experience digital eye strain. As an emerging public health concern, patients need to be educated on the damaging vision effects tied to regular digital device use.
Evidence has linked the functional activity of our microbiome to biological processes that influence human wellness. See what factors may have the potential to reduce DR severity in humans independently of hyperglycemia.
MIGS offer a middle option to manage glaucoma, filling the gap between topical medication and laser or filtration surgery. ODs need to understand which patients are the best candidates and how to manage them postop.
This is a post-only, outbound email. Please do not reply to this email as we will be unable to respond to your reply. Please use the links provided if you have questions or concerns regarding this email or your subscription.
This email was sent by: %%Member_Busname%% %%Member_Addr%% %%Member_City%%, %%Member_State%%, %%Member_PostalCode%%, %%Member_Country%%
